iifl-logo

Alkem Laboratories Ltd AGM

4,835.55
(-0.95%)
Apr 1, 2025|12:00:00 AM

Alkem Lab CORPORATE ACTIONS

02/04/2024calendar-icon
02/04/2025calendar-icon
PurposeAGM DateAnnouncement Date
AGM30 Aug 202429 May 2024
Please find enclosed herewith the outcome of the Board meeting dated 29th May, 2024 The BOD at its meeting held today has fixred 10.8.24 as the record date for payment of final dividend and 23.08.24 as cut off date for purpose of AGM (As Per BSE Announcement Dated on 29.05.2024) Please find enclosed herewith the details regarding the brief proceedings of 50th Annual General Meeting (AGM) of the Company held on 30th August, 2024 at 11.00 a.m. through Video Conferencing (VC) / Other Audio Visual Means (OAVM) and the details regarding the voting results of the business transacted at the said AGM in the prescribed format. Further we are also enclosing the Report of the Scrutinizer on remote e-voting and e-voting during the AGM. Kindly take the same on record. (As per BSE Announcement Dated on 30/08/2024)

Alkem Lab: Related News

Alkem Labs' Taloja Bioequivalence Center Clears USFDA Inspection
16 Mar 2025|10:04 PM

This inspection, conducted from March 10 through March 13, 2025, was to evaluate compliance with the legal standards concerning bioequivalence studies.

Read More
Alkem Laboratories Q3 Profit Rises 5% YoY
9 Feb 2025|10:44 PM

The company saw its revenues increase by 1.5% YoY at ₹3,374 crore from ₹3,324 crore.

Read More
Alkem Launches Kojiglo Serum in India for Hyperpigmentation Treatment
5 Feb 2025|11:24 AM

The serum contains liposomal azelaic acid, liposomal 4-butyl resorcinol, tranexamic acid, alpha arbutin, and niacinamide.

Read More
Alkem Labs Q2 Profit Rises 11% to ₹689 Crore
14 Nov 2024|01:38 PM

R&D expenses rose to ₹146.5 crore, making up 4.3% of total revenue, compared to ₹115.8 crore (3.4% of revenue) in the previous year.

Read More
Cipla, Alkem Vie for SMT Acquisition
16 Oct 2024|11:29 AM

This comes after competing private equity firms TPG Capital, Apax Partners, and KKR withdrew their original interest.

Read More
Alkem Partners with Sonnet for Diabetic Neuropathy Drug in India
11 Oct 2024|12:24 PM

Alkem will conduct clinical trials of 'SON-080' in India, with Sonnet's support for global and local regulatory submissions.

Read More
Alkem Laboratories’ equity worth ₹487 Crore change hands
22 Aug 2024|11:12 AM

According to sources, the floor price would be ₹5,616 per share, which is 3% lower than the current market price (CMP).

Read More
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.